BioPharma
Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control
The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's bio sovereignty movement. Countries like China, India, Japan, South Korea, and Singapore are making daring...
BioPharma
Digital Twins in Biomanufacturing: APAC’s Leap in Innovation
The Asia-Pacific (APAC) region is fast embracing biomanufacturing, leading-edge technology that is poised to redefine manufacturing processes and efficiency. One of the most revolutionary of these technologies is bringing digital twin technology into play. With the industry facing elevated...
BioPharma
AI Drug Discovery Transforming APAC Biopharma Innovation
The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug discovery is not just a fad but a paradigm shift transforming the way new...
BioPharma
CDMO Market For Small Molecule Innovation Soars By 2033
It has been anticipated that the market for contract development and manufacturing organizations (CDMOs) that specialize in small molecule innovation would reach a value of $48.09 billion in 2023 and $89.43 billion in 2033. This information comes from several...
BioPharma
The Biopharma CDMO Market Surges With Outsourcing Growth
A recent study found that 86.9% of biopharmaceutical companies outsource at least some of their work. This has helped to build the $14 billion biopharmaceutical contract manufacturing business.
The researchers forecast a highly promising and profitable future for biopharmaceutical contract...
BioPharma
Biotech And CDMOs: Overcoming Drug Development Challenges
In today's fast-paced market, biotech firms continue to encounter many hurdles, especially during the clinical phase of drug development. Biologics may pose significant technical and commercial risks due to their exorbitant prices, intricate production procedures, and regulatory barriers. Nevertheless,...
BioPharma
Projected Growth of Injectable Drug Market To $1139B By 2029
According to a recent analysis released by MarketsandMarkets, the injectable medication delivery market is expected to grow at a compound annual growth rate (CAGR) of about 9% between 2024 and 2029.
By 2029, this market is projected to be worth...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.